How to assess ischaemic MR?

Similar documents
Guidelines in perspective?

What echo measurements are key prior to MitraClip?

Valvular Regurgitation: Can We Do Better Than Colour Doppler?

Secondary MR joint with the mitral academy. What is new in our understanding of this disease? Luc Pierard University Hospital, Liège

Professors Carpentier and McGoon Mechanism, resulting from the disease Severity of regurgitation, resulting from the mechanism Echo

Primary Mitral Regurgitation

MR echo case. N.Koutsogiannis Department of Cardiology University Hospital Of Patras

Disclosures Rebecca T. Hahn, MD, FASE

Functional Mitral Regurgitation

What are the best diagnostic tools to quantify aortic regurgitation?

Marti McCulloch, BS, MBA, RDCS, FASE Houston, Texas

Regurgitant Lesions. Bicol Hospital, Legazpi City, Philippines July Gregg S. Pressman MD, FACC, FASE Einstein Medical Center Philadelphia, USA

Tricuspid and Pulmonary Valve Disease

Ischemic Mitral Regurgitation

Prof. JL Zamorano Hospital Universitario Ramón y Cajal

The difficult patient with mitral regurgitation

Imaging MV. Jeroen J. Bax Leiden University Medical Center The Netherlands Davos, feb 2015

Case Reviews: Hemodynamic Calculations in Valvular Regurgitation

EVALUATION OF CHRONIC MITRAL REGURGITATION: ASSESSING MECHANISMS AND QUANTIFYING SEVERITY 2018 STRUCTURAL HEART DISEASE CONFERENCE June 1, 2018

Hemodynamic Assessment. Assessment of Systolic Function Doppler Hemodynamics

PISA Evaluation of Mitral Regurgitation. Raymond Graber, MD Cardiac Anesthesia Group University Hospitals Case Medical Center 4/07/2011

New 3D Quantification of Mitral Regurgitation Severity. Judy Hung, MD Cardiac Ultrasound Laboratory Massachusetts General Hospital Boston, MA

Clinical Outcome of Tricuspid Regurgitation. David Messika-Zeitoun

MITRAL REGURGITATION ECHO PARAMETERS TOOL

LUST trial. Echocardiography USER S MANUAL

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM

Echocardiography. Guidelines for Valve and Chamber Quantification. In partnership with

Exercise Pulmonary Hypertension predicts the Occurrence of Symptoms in Asymptomatic Degenerative Mitral Regurgitation

Tricuspid and Pulmonary Valve Disease

Ioannis Alexanian, MD, PhD Department of Cardiology General Hospital of Chest Diseases Sotiria Athens

What Degree of MR Deserves Surgical or Transcatheter Intervention, and How Should It Be Assessed?

Quantification of MR

Index. B B-type natriuretic peptide (BNP), 76

ECHOCARDIOGRAPHY DATA REPORT FORM

LV geometric and functional changes in VHD: How to assess? Mi-Seung Shin M.D., Ph.D. Gachon University Gil Hospital

Dobutamine Stress testing In Low Flow, Low EF, Low Gradient Aortic Stenosis Case Studies

ASE Guidelines on Aortic Regurgitation What Do I Measure? Case Studies

CHAPTER 4 AN EFFICACIOUS APPROACH FOR THE QUANTIFICATION OF MITRAL REGURGITATION USING IMAGE PROCESSING AND PROXIMAL FLOW CONVERGENCE METHOD

Quantifying Aortic Regurgitation

The Doppler Examination. Katie Twomley, MD Wake Forest Baptist Health - Lexington

Echocardiography: Guidelines for Valve Quantification

How does Pulmonary Hypertension Affect the Decision to Intervene in Mitral Valve Disease? NO DISCLOSURE

Introduction RECOMMENDATIONS

Exercise-Induced Changes in Degenerative Mitral Regurgitation

Evaluation of Left Ventricular Diastolic Dysfunction by Doppler and 2D Speckle-tracking Imaging in Patients with Primary Pulmonary Hypertension

Direct Planimetry of Mitral Valve Regurgitation Orifice Area by Real-time 3D Transesophageal Echocardiography

Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention

LV FUNCTION ASSESSMENT: WHAT IS BEYOND EJECTION FRACTION

Quantification of Aortic Regurgitation

Advanced Evaluation of Left Ventricular Function in Degenerative MR. Dr Julien Magne, PhD University of Liege, CHU Sart Tilman, Liege, Belgium

MITRAL VALVE PATHOLOGY WITH TRICUSPID REGURGITATION (AND PHT)

Determinants of Exercise-Induced Changes in Mitral Regurgitation in Patients With Coronary Artery Disease and Left Ventricular Dysfunction

AATS Annual Meeting Seattle, WA Irving Kron, M.D. Professor and Chairman Department of Surgery University of Virginia Hospital Charlottesville,

Exercise echocardiography in the evaluation of functional mitral regurgitation: A systematic review of the literature

ECHO HAWAII. Role of Stress Echo in Valvular Heart Disease. Not only ischemia! Cardiomyopathy. Prosthetic Valve. Diastolic Dysfunction

Outline. EuroScore II. Society of Thoracic Surgeons Score. EuroScore II

Assessing Function by Echocardiography in VHD Asymptomatic Severe Organic MR. Dr. Julien Magne, PhD Sart Tilman Liège, BELGIUM

NEW GUIDELINES. A Guideline Protocol for the Assessment of Aortic Regurgitation From the British Society of Echocardiography Education Committee

Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat

The Key Questions in Mitral Valve Interventions. Where Are We in 2018?

Επιδιόπθωζη μιηποειδικήρ ζςζκεςήρ ζε ππόπηωζη ή πήξη γλωσίνων. Βαζίλειορ Σασπεκίδηρ Επιμεληηήρ Β Καπδιολογίαρ Γ.Ν. Παπαγεωπγίος

Chronic Ischemic Mitral Regurgitation

When should we intervene surgically in pediatric patient with MR?

Doppler Basic & Hemodynamic Calculations

Evaluation of the Right Ventricle in Candidates for Right Ventricular Assist Device Implantation.

Late secondary TR after left sided heart disease correction: is it predictibale and preventable

Aortic Stenosis: Spectrum of Disease, Low Flow/Low Gradient and Variants

Who will Benefit from Percutaneous Management of Mitral Regurgitation? An Imaging Guide to Management

Echo Doppler Assessment of Right and Left Ventricular Hemodynamics.

Echocardiographic evaluation of mitral stenosis

Echocardiographic Evaluation of the Cardiomyopathies. Stephanie Coulter, MD, FACC, FASE April, 2016

Aortic Regurgitation & Aorta Evaluation

25 different brand names >44 different models Sizes mm

DOPPLER HEMODYNAMICS (1) QUANTIFICATION OF PRESSURE GRADIENTS and INTRACARDIAC PRESSURES

2/2/2011. Strain and Strain Rate Imaging How, Why and When? Movement vs Deformation. Doppler Myocardial Velocities. Movement. Deformation.

Comprehensive Hemodynamics By Doppler Echocardiography. The Echocardiographic Swan-Ganz Catheter.

School, The University of Texas Health Science Center at Houston, TX.

Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017

Improvements in outcomes for heart valve surgery, in particular mitral valve repair, have dictated

Ιπποκράτειες μέρες καρδιολογίας Θεσσαλονίκη, 9-10 Μαρτίου Φωτεινή Α. Λαζαρίδου Επιμελήτρια Α Γενικό Νοσοκομείο Αγιος Παύλος, Θεσσαλονίκη

Questions on Chamber Quantitation

ESC/EACTS Guidelines for the Management of Valvular Heart Disease

British Society of Echocardiography

좌심실수축기능평가 Cardiac Function

When Does 3D Echo Make A Difference?

Χειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας

Echocardiography as a diagnostic and management tool in medical emergencies

Aortic Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines -

Burden of Mitral Regurgitation (MR) in the US Why is This Important?

AIMI-HF PROCEDURE MANUAL TECHNICAL GUIDE FOR ECHOCARDIOGRAPHY. MHI Core Laboratory E. O Meara - J.C. Tardif J. Vincent, G. Grenier, C.

Chronic ischaemic mitral regurgitation. Current treatment results and new mechanism-based surgical approaches

Quantification of Mitral Stenosis: Planimetry, pressure Half time, Continuity Common Errors

Normal TTE/TEE Examinations

Basic Approach to the Echocardiographic Evaluation of Ventricular Diastolic Function

HEART VALVE DISEASES. Dr. James Kadouch Medical Officer Cardiologist Delphine Labojka Method & Process Manager

Appendix II: ECHOCARDIOGRAPHY ANALYSIS

Exercise Testing/Echocardiography in Asymptomatic AS

ΔΙΑΔΕΡΜΙΚΗ ΑΝΤΙΜΕΤΩΠΙΣΗ ΔΟΜΙΚΩΝ ΠΑΘΗΣΕΩΝ: Ο ΡΟΛΟΣ ΤΗΣ ΑΠΕΙΚΟΝΙΣΗΣ ΣΤΟ ΑΙΜΟΔΥΝΑΜΙΚΟ ΕΡΓΑΣΤΗΡΙΟ ΣΤΗΝ ΤΟΠΟΘΕΤΗΣΗ MITRACLIP

Quantitation of right ventricular dimensions and function

Transcription:

ESC 2012 How to assess ischaemic MR? Luc A. Pierard, MD, PhD, FESC, FACC Professor of Medicine Head, Department of Cardiology University Hospital Sart Tilman, Liège

ESC 2012 No conflict of interest Luc A. Pierard, MD, PhD, FESC, FACC Professor of Medicine Head, Department of Cardiology University Hospital Sart Tilman, Liège

Ischaemic mitral regurgitation

Carpentier s functional classification TYPE I : NORMAL LEAFLET MOTION - Annular dilatation - Leaflet perforation TYPE II : EXCESSIVE LEAFLET MOTION - Prolapse - Flail TYPE III : REDUCED LEAFLET MOTION - SYSTOLE AND DIASTOLE: Chordae shortening, leaflet thickening - SYSTOLE: Incomplete coaptation

What should we assess? Mechanism(s) Quantified severity of MR Dynamic component Myocardial state Dyssynchrony Markers of MV repair failure

Secondary MR Tethering force PMs displacement Dilation/Sphericity Annular dilation Closing force Reduced contractility Asynchrony PMs dyssynchrony Reduced annular contraction Global and Local LV Remodeling LV Asynchrony Mitral valve deformation

If tethering is normal, MR develops only when mitral annulus area is 75% above baseline

Assessment of tethering forces Postero-lateral angle Systolic tenting area Coaptation distance

Assessment of closing force Reduced contractility LV dyssynchrony

Ao MR No MR Ao Baseline Normal Post-Infarct PM functioning Post-Infarct PM ischemic

Papillary muscle dysfunction and secondary MR Normal Post-Infarct PM functioning Post-Infarct PM ischemic LV PM contraction PM dysfunction LA Ao Messas E et al, Circulation 2001;104:1952-1957

What should we assess? Mechanism(s) Quantified severity of MR Dynamic component Myocardial state Dyssynchrony Markers of MV repair failure

Physical examination Desjardins et al Am J Med 1996,100,149

Degree of regurgitation - Regurgitation area - Vena contracta width - Effective regurgitation orifice area - Regurgitant volume

Regurgitant area: should be abandoned Gain Scale

Vena contracta width The narrowest portion of the MR jet downstream from the orifice 2 orthogonal planes Zoom to optimize visualization Colour sector as narrow as possible Maximal lateral and temporal resolution # Mild MR : VC < 0.3 cm # Severe MR: VC 0.7 cm

Doppler volumetric method Not applicable if significant aortic regurgitation Calculate LVOT stroke volume LVOT SV = LVOT diameter² x 0.785 x LVO TVI Calculate Mitral Inflow stroke volume MI SV = mitral annulus diameter² x 0.785 x MI TVI Substract LVOT SV from MI SV = RV Measure MV TVI by continuous-wave Doppler ERO = MV Reg V / MR TVI

PISA Method 1. Optimize 2-D colour (AP-4CV) 2. Zoom or RES 3. Colour-flow baseline shift downwards to increase PISA (15-40 cm/s) 4. Measure PISA radius at mid systole using the first aliasing 5. Measure MR peak velocity and TVI ( CW Doppler ) 6. Calculate mitral flow rate, ERO and RV

Variance OFF

Effective regurgitant orifice and regurgitant volume Flow rate at PISA = Flow rate at regurgitant orifice 2 r² x Aliasing velocity = ERO x MR velocity ERO = 6.28 r² x Alia vel / MR vel Reg Vol = ERO x MR TVI

Limitations of the PISA method Isovelocity surface not always a hemisphere Contour flattening of the orifice Underestimation Va /Vmax > 10 % (if high Va) ----> ideal Va 20-40 cm/s Phasic changes

3 D PISA and Vena contracta width

Echocardiographic criteria for the definition of severe valve regurgitation: an integrative approach Aortic regurgitation Mitral regurgitation Tricuspid regurgitation Semiquantitative Vena contracta width (mm) > 6 7 (> 8 for biplane) 7 Upstream vein flow Inflow Other Pressure half-time < 200 ms Systolic pulmonary vein flow reversal E-wave dominant 1.5 m/s TVI mitral/tvi aortic > 1.4 Quantitative Primary Secondary Systolic hepatic vein flow reversal E-wave dominant 1 m/s PISA radius > 9 mm EROA (mm²) 30 40 20 40 R Vol (ml/beat) 60 60 30 45 + enlargement of cardiac chambers/ vessels LV LV, LA Adapted from Lancellotti, EAE recommendations. Eur J Echocardiogr. 2010;11:223-244 and 307-332 RV, RA, inferior vena cava European Heart Journal 2012 - doi:10.1093/eurheartj/ehs109 & European Journal of Cardio-Thoracic Surgery 2012 - doi:10.1093/ejcts/ezs455).

Severe ischaemic MR: ERO 20 mm² MI > 16 days NYHA Class IV MI > 6 months No NYHA IV Grigioni et al Circulation 2001, 103; 1759 Lancellotti, Pierard et al Circulation 2003, 108:1713

What should we assess? Mechanism(s) Quantified severity of MR Dynamic component Myocardial state Dyssynchrony Markers of MV repair failure

Ischaemic MR is dynamic Rest Increase with exercise Rest Decrease with exercise

Which measurement of MR severity? Interobserver variability 1.0 PISA DOPPLER r 0.5 RJA VCW 0.0 Lebrun, Lancellotti, Piérard JACC 2001; 38:1685-1692

REST : Ischaemic mitral regurgitation

VC width = 5 mm ERO = 6.28 x (0.78)²x 33 5.8 ERO = 22 mm² RV = 22 x 1.85 = 40 ml TTPG = 36 mmhg

Doppler Echocardiography during exercise Exercise-induced dyspnea

EXERCISE: Dynamic ischaemic MR

VC width = 7 mm ERO = 6.28 x (1.1)²x 33 6.6 ERO = 38 mm² (+ 16) RV = 38 x 1.81 = 69 ml (+ 29) TTPG = 77 mmhg (+ 41)

Exercise-induced dyspnea vs fatigue 103 fatigue 58 dyspnea Piérard, Lancellotti N Engl J Med 2006;354:871-2

ΔEx.-rest OR p Recent APE ERO 1.15 (1.05-1.25) < 0.001 TTPG 1.13 (1.05-1.21) 0.001 LVEF 0.86 (0.77-0.96) 0.02

Long-term prognosis of dynamic ischaemic MR Survival Decompensated HF Lancellotti et al Circulation 2003;108:1713-7 Lancellotti, Gérard, Piérard Eur Heart J 2005;26:1528-32

What should we assess? Mechanism(s) Quantified severity of MR Dynamic component Myocardial state Dyssynchrony Markers of MV repair failure

REST DOBUTAMINE preload afterload contractility Assessment of contractile reserve inducible ischaemia

No contractile reserve No evidence of inducible ischaemia REST EXERCISE

Biphasic response during exercise

What should we assess? Mechanism(s) Quantified severity of MR Dynamic component Myocardial state LV dyssynchrony Markers of MV repair failure

LV dysynchrony

Before CRT Early Late Mitral Regurgitation (%) OFF ON Breithardt et al JACC 2003; 41: 765-770 40 35 30 25 20 15 10 Baseline 1wk 1mo 3mo offimmed off- 1wk off- 4wk

What should we assess? Mechanism(s) Quantified severity of MR Dynamic component Myocardial state Dyssynchrony Markers of MV repair failure

Markers of MV repair failure Postero-lateral angle Tenting area Coaptation distance - Posterolateral angle > 45 - Tenting area > 2.5-3 cm² - Coaptation distance 1 cm

How to assess ischaemic MR? Mechanism(s) Quantified severity of MR Dynamic component Myocardial state Dyssynchrony Markers of MV repair failure